rs34189216
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001353108.3(CEP63):c.1155C>A(p.Asn385Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0013 in 1,610,376 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0069 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00073 ( 11 hom. )
Consequence
CEP63
NM_001353108.3 missense
NM_001353108.3 missense
Scores
6
12
Clinical Significance
Conservation
PhyloP100: 1.27
Genes affected
CEP63 (HGNC:25815): (centrosomal protein 63) This gene encodes a protein with six coiled-coil domains. The protein is localized to the centrosome, a non-membraneous organelle that functions as the major microtubule-organizing center in animal cells. Several alternatively spliced transcript variants have been found, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0047411025).
BP6
Variant 3-134549149-C-A is Benign according to our data. Variant chr3-134549149-C-A is described in ClinVar as [Benign]. Clinvar id is 128707.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-134549149-C-A is described in Lovd as [Benign]. Variant chr3-134549149-C-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00685 (1043/152184) while in subpopulation AFR AF= 0.023 (953/41516). AF 95% confidence interval is 0.0217. There are 7 homozygotes in gnomad4. There are 488 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 7 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEP63 | NM_001353108.3 | c.1155C>A | p.Asn385Lys | missense_variant | 10/15 | ENST00000675561.1 | NP_001340037.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP63 | ENST00000675561.1 | c.1155C>A | p.Asn385Lys | missense_variant | 10/15 | NM_001353108.3 | ENSP00000502085.1 |
Frequencies
GnomAD3 genomes AF: 0.00685 AC: 1042AN: 152066Hom.: 8 Cov.: 32
GnomAD3 genomes
AF:
AC:
1042
AN:
152066
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00217 AC: 545AN: 250994Hom.: 6 AF XY: 0.00170 AC XY: 231AN XY: 135648
GnomAD3 exomes
AF:
AC:
545
AN:
250994
Hom.:
AF XY:
AC XY:
231
AN XY:
135648
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000726 AC: 1058AN: 1458192Hom.: 11 Cov.: 29 AF XY: 0.000581 AC XY: 422AN XY: 725734
GnomAD4 exome
AF:
AC:
1058
AN:
1458192
Hom.:
Cov.:
29
AF XY:
AC XY:
422
AN XY:
725734
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00685 AC: 1043AN: 152184Hom.: 7 Cov.: 32 AF XY: 0.00656 AC XY: 488AN XY: 74390
GnomAD4 genome
AF:
AC:
1043
AN:
152184
Hom.:
Cov.:
32
AF XY:
AC XY:
488
AN XY:
74390
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
110
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
311
Asia WGS
AF:
AC:
2
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | - - |
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 16, 2013 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;.;.;T;T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D;D;.;.;D;D
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;.;.;M;M;M;M;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.;N;N;.;N;N
REVEL
Benign
Sift
Benign
T;T;.;T;T;.;T;T
Sift4G
Benign
T;T;T;T;T;T;T;T
Polyphen
B;P;P;P;D;D;D;.
Vest4
MutPred
0.28
.;.;.;Gain of ubiquitination at N385 (P = 0.0109);Gain of ubiquitination at N385 (P = 0.0109);Gain of ubiquitination at N385 (P = 0.0109);Gain of ubiquitination at N385 (P = 0.0109);.;
MVP
MPC
0.095
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at